$MYGN
MYRIAD GENETICS INC

2013 Q2 Form 10-Q Financial Statement

#000119312513206264 Filed on May 08, 2013

View on sec.gov

Income Statement

Concept 2013 Q2 2013 Q1 2012 Q1
Revenue $174.1M $156.5M $129.8M
YoY Change 30.9% 20.57% 26.74%
Cost Of Revenue $22.10M $16.46M $13.47M
YoY Change 30.0% 22.26% 21.31%
Gross Profit $152.0M $140.0M $116.3M
YoY Change 31.03% 20.37% 27.54%
Gross Profit Margin 87.31% 89.48% 89.62%
Selling, General & Admin $71.50M $64.60M $54.70M
YoY Change 26.33% 18.1% 27.8%
% of Gross Profit 47.04% 46.14% 47.03%
Research & Development $14.60M $13.62M $11.75M
YoY Change 20.66% 15.87% 75.42%
% of Gross Profit 9.61% 9.73% 10.1%
Depreciation & Amortization $2.300M $2.100M $2.300M
YoY Change -4.17% -8.7% 27.78%
% of Gross Profit 1.51% 1.5% 1.98%
Operating Expenses $86.10M $78.22M $66.45M
YoY Change 25.33% 17.71% 34.25%
Operating Profit $65.90M $57.92M $46.10M
YoY Change 39.32% 25.65% 10.54%
Interest Expense $1.300M $1.400M $1.400M
YoY Change -7.14% 0.0% 180.0%
% of Operating Profit 1.97% 2.42% 3.04%
Other Income/Expense, Net $0.00 $1.323M $0.00
YoY Change -100.0% -100.0%
Pretax Income $67.20M $59.24M $47.48M
YoY Change 38.56% 24.77% 12.25%
Income Tax $23.20M $21.35M $17.87M
% Of Pretax Income 34.52% 36.04% 37.63%
Net Earnings $44.10M $37.89M $29.62M
YoY Change 51.55% 27.95% 6.15%
Net Earnings / Revenue 25.33% 24.22% 22.82%
Basic Earnings Per Share $0.47 $0.35
Diluted Earnings Per Share $533.3K $0.46 $0.34
COMMON SHARES
Basic Shares Outstanding 79.65M shares 80.38M shares 84.40M shares
Diluted Shares Outstanding 82.43M shares 86.46M shares

Balance Sheet

Concept 2013 Q2 2013 Q1 2012 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $372.3M $336.2M $337.4M
YoY Change 9.34% -0.36% -6.59%
Cash & Equivalents $104.1M $112.3M $104.9M
Short-Term Investments $268.2M $223.8M $232.5M
Other Short-Term Assets $9.700M $9.000M $18.50M
YoY Change 32.88% -51.35% 180.3%
Inventory $5.007M $7.136M $10.40M
Prepaid Expenses $956.0K $1.541M
Receivables $94.33M $93.17M $50.90M
Other Receivables $2.645M $2.200M $1.500M
Total Short-Term Assets $484.0M $447.7M $418.7M
YoY Change 14.56% 6.93% 0.75%
LONG-TERM ASSETS
Property, Plant & Equipment $27.60M $26.88M $24.10M
YoY Change 13.91% 11.51% 13.15%
Goodwill $56.90M $56.85M
YoY Change 0.09%
Intangibles $13.33M $13.53M
YoY Change -15.21%
Long-Term Investments $158.7M $126.1M $129.3M
YoY Change 39.58% -2.47% 43.19%
Other Assets $13.00M $37.00M $36.00M
YoY Change -66.32% 2.78% 27.66%
Total Long-Term Assets $319.8M $281.3M $280.6M
YoY Change 19.28% 0.26% 98.02%
TOTAL ASSETS
Total Short-Term Assets $484.0M $447.7M $418.7M
Total Long-Term Assets $319.8M $281.3M $280.6M
Total Assets $803.8M $729.0M $699.3M
YoY Change 16.39% 4.25% 25.48%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $18.13M $12.24M $7.900M
YoY Change 78.8% 54.91% 51.92%
Accrued Expenses $44.33M $38.35M $27.70M
YoY Change 35.28% 38.45% 52.2%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $64.51M $53.62M $37.10M
YoY Change 43.46% 44.53% 58.55%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $10.70M $10.50M $10.00M
YoY Change 7.0% 5.0% 6.38%
Total Long-Term Liabilities $10.70M $10.50M $10.00M
YoY Change 7.0% 5.0% 6.38%
TOTAL LIABILITIES
Total Short-Term Liabilities $64.51M $53.62M $37.10M
Total Long-Term Liabilities $10.70M $10.50M $10.00M
Total Liabilities $75.23M $64.10M $47.10M
YoY Change 36.84% 36.09% 43.6%
SHAREHOLDERS EQUITY
Retained Earnings $30.87M $2.050M
YoY Change -343.35%
Common Stock $806.0K $797.0K
YoY Change -2.42%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $728.6M $664.9M $652.2M
YoY Change
Total Liabilities & Shareholders Equity $803.8M $729.0M $699.3M
YoY Change 16.39% 4.25% 25.48%

Cashflow Statement

Concept 2013 Q2 2013 Q1 2012 Q1
OPERATING ACTIVITIES
Net Income $44.10M $37.89M $29.62M
YoY Change 51.55% 27.95% 6.15%
Depreciation, Depletion And Amortization $2.300M $2.100M $2.300M
YoY Change -4.17% -8.7% 27.78%
Cash From Operating Activities $63.00M $37.40M $40.70M
YoY Change 51.08% -8.11% 44.84%
INVESTING ACTIVITIES
Capital Expenditures -$2.800M -$1.600M -$2.000M
YoY Change 21.74% -20.0% 900.0%
Acquisitions
YoY Change
Other Investing Activities -$81.80M $49.60M -$41.80M
YoY Change 1286.44% -218.66% -198.12%
Cash From Investing Activities -$84.60M $48.00M -$43.80M
YoY Change 931.71% -209.59% -203.3%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 13.30M -41.50M -900.0K
YoY Change -125.58% 4511.11% -98.73%
NET CHANGE
Cash From Operating Activities 63.00M 37.40M 40.70M
Cash From Investing Activities -84.60M 48.00M -43.80M
Cash From Financing Activities 13.30M -41.50M -900.0K
Net Change In Cash -8.300M 43.90M -4.000M
YoY Change -55.14% -1197.5% 1233.33%
FREE CASH FLOW
Cash From Operating Activities $63.00M $37.40M $40.70M
Capital Expenditures -$2.800M -$1.600M -$2.000M
Free Cash Flow $65.80M $39.00M $42.70M
YoY Change 49.55% -8.67% 50.88%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
79654860 shares
CY2011Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
52681000
CY2012Q2 us-gaap Goodwill
Goodwill
56850000
CY2012Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
72528000
CY2012Q2 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
5572000
CY2012Q2 us-gaap Stockholders Equity
StockholdersEquity
635660000
CY2012Q2 us-gaap Other Assets
OtherAssets
8000000
CY2012Q2 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
113692000
CY2012Q2 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
54728000
CY2012Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2012Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
82569000 shares
CY2012Q2 us-gaap Notes Receivable Net
NotesReceivableNet
19000000
CY2012Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
254180000
CY2012Q2 us-gaap Liabilities
Liabilities
54975000
CY2012Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
10141000
CY2012Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
10008000
CY2012Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1713000
CY2012Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
2054000
CY2012Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2012Q2 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
30648000
CY2012Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-12684000
CY2012Q2 us-gaap Assets
Assets
690635000
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
19.32
CY2012Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
60441000
CY2012Q2 us-gaap Inventory Net
InventoryNet
11574000
CY2012Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
420007000
CY2012Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2012Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
690635000
CY2012Q2 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
17800000
CY2012Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
86352000
CY2012Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
82569000 shares
CY2012Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
15722000
CY2012Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-162000
CY2012Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
32772000
CY2012Q2 us-gaap Liabilities Current
LiabilitiesCurrent
44967000
CY2012Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4600000
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
15233281 shares
CY2012Q2 us-gaap Common Stock Value
CommonStockValue
826000
CY2012Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q2 us-gaap Assets Current
AssetsCurrent
422492000
CY2012Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2012Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2012Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2012Q2 us-gaap Other Receivables
OtherReceivables
2660000
CY2012Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
48297000
CY2012Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
24231000
CY2012Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
647680000
CY2013Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
81074000
CY2013Q1 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
7512000
CY2012Q3 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.07 pure
CY2012Q3 mygn Fair Value Option Loans Aggregate Principal Amount Outstanding
FairValueOptionLoansAggregatePrincipalAmountOutstanding
8000000
CY2011Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
25000000
CY2011Q3 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.06 pure
CY2012Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
104852000
CY2013Q1 us-gaap Goodwill
Goodwill
56850000
CY2013Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
223834000
CY2013Q1 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
1350000
CY2013Q1 us-gaap Stockholders Equity
StockholdersEquity
664929000
CY2013Q1 us-gaap Other Assets
OtherAssets
8000000
CY2013Q1 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
126120000
CY2013Q1 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
62828000
CY2013Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
42009000
CY2013Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2013Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
79816000 shares
CY2013Q1 us-gaap Notes Receivable Net
NotesReceivableNet
21000000
CY2013Q1 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
223834000
CY2013Q1 us-gaap Liabilities
Liabilities
64099000
CY2013Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
12238000
CY2013Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
124472000
CY2013Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
10478000
CY2013Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1541000
CY2013Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
3031000
CY2013Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2013Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
223711000
CY2013Q1 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
28953000
CY2013Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2050000
CY2013Q1 us-gaap Assets
Assets
729028000
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
21.38
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
20.11
CY2013Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
93172000
CY2013Q1 us-gaap Inventory Net
InventoryNet
7136000
CY2013Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
431158000
CY2013Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
729028000
CY2013Q1 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
18246000
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
112323000
CY2013Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
79816000 shares
CY2013Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
13525000
CY2013Q1 us-gaap Available For Sale Securities Debt Maturities Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost
462004000
CY2013Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-459000
CY2013Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
38352000
CY2013Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
124770000
CY2013Q1 us-gaap Liabilities Current
LiabilitiesCurrent
53621000
CY2013Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6300000
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
16074604 shares
CY2013Q1 us-gaap Common Stock Value
CommonStockValue
797000
CY2013Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2013Q1 us-gaap Assets Current
AssetsCurrent
447705000
CY2013Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
dei Document Period End Date
DocumentPeriodEndDate
2013-03-31
dei Entity Central Index Key
EntityCentralIndexKey
0000899923
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
us-gaap Costs And Expenses
CostsAndExpenses
276964000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6635000
CY2013Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2013Q1 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
1500000
CY2013Q1 us-gaap Other Receivables
OtherReceivables
2187000
CY2013Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
54199000
CY2013Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
26875000
CY2013Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
662541000
CY2013Q1 mygn Cash And Cash Equivalents And Available For Sale Securities Debt Maturities Estimated Fair Value
CashAndCashEquivalentsAndAvailableForSaleSecuritiesDebtMaturitiesEstimatedFairValue
462277000
CY2013Q1 mygn Residual Value Of Loan Agreement
ResidualValueOfLoanAgreement
17000000
dei Trading Symbol
TradingSymbol
MYGN
dei Entity Registrant Name
EntityRegistrantName
MYRIAD GENETICS INC
dei Amendment Flag
AmendmentFlag
false
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Type
DocumentType
10-Q
us-gaap Operating Income Loss
OperatingIncomeLoss
162086000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
8811530 shares
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2097000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-4000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
102767000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
25506000
us-gaap Share Based Compensation
ShareBasedCompensation
20435000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
27.11
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.23
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
8582000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
22.18
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
23103000
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1818004 shares
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
1490000
us-gaap Basis Of Accounting
BasisOfAccounting
<div> <table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left"><font style="font-family:Times New Roman" size="2">(1)</font></td> <td align="left" valign="top"><font style="font-family:Times New Roman" size="2"><u>Basis of Presentation</u></font></td> </tr> </table> <p style="margin-top:6px;margin-bottom:0px"><font style="font-family:Times New Roman" size="2">The accompanying condensed consolidated financial statements have been prepared by Myriad Genetics, Inc. (the &#x201C;Company&#x201D;) in accordance with U.S. generally accepted accounting principles (&#x201C;GAAP&#x201D;) for interim financial information and pursuant to the applicable rules and regulations of the Securities and Exchange Commission (&#x201C;SEC&#x201D;). The condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. In the opinion of management, the accompanying financial statements contain all adjustments (consisting of normal and recurring accruals) necessary to present fairly all financial statements in accordance with GAAP. The condensed consolidated financial statements herein should be read in conjunction with the Company&#x2019;s audited consolidated financial statements and notes thereto for the fiscal year ended June&#xA0;30, 2012, included in the Company&#x2019;s Annual Report on Form 10-K for the fiscal year ended June&#xA0;30, 2012. Operating results for the three and nine months ended March&#xA0;31, 2013 may not necessarily be indicative of results to be expected for any other interim period or for the full year.</font></p> <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:Times New Roman" size="2">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</font></p> </div>
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
124705000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.38 pure
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
110866000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
9039000
us-gaap Investment Income Interest
InvestmentIncomeInterest
4187000
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
224000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
977000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
13.14
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-5020000
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-224000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
25971000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y6M
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
83544000 shares
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
55834000
us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
4805000 shares
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-566000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
166049000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.27
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
39125000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-93934000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-178000
us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
470000
us-gaap Cost Of Revenue
CostOfRevenue
45960000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
81219000 shares
us-gaap Other Operating Income
OtherOperatingIncome
3963000
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
5265000
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
2000000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 Segment
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-4438000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
2325000 shares
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35 pure
us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
11585000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
238296 shares
us-gaap Revenues
Revenues
439050000
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
416304000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
281774000
us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
22746000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P4Y
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4975000 shares
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
299395000
us-gaap Net Income Loss
NetIncomeLoss
103065000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
5265000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
180294000
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-473000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
2897623 shares
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
62984000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
268000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
701000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
5580000
mygn Segment Reporting Depreciation And Amortization
SegmentReportingDepreciationAndAmortization
6635000
mygn Amount Charged To Retained Earnings As Result Of Stock Repurchases
AmountChargedToRetainedEarningsAsResultOfStockRepurchases
88331000
mygn Amount Of Reduction In Common Stock As Result Of Stock Repurchases
AmountOfReductionInCommonStockAsResultOfStockRepurchases
36374000
mygn Income Related To Accretion Of Note Receivable And Stated Interest Rate
IncomeRelatedToAccretionOfNoteReceivableAndStatedInterestRate
3306000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
799000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-206000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
82759000
us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
100000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
18058000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6741000
us-gaap Share Based Compensation
ShareBasedCompensation
19859000
mygn Share Based Compensation Arrangement Common Shares Eligible For Purchase Related To Options Vested And Exercisable Number
ShareBasedCompensationArrangementCommonSharesEligibleForPurchaseRelatedToOptionsVestedAndExercisableNumber
9122023 shares
us-gaap Costs And Expenses
CostsAndExpenses
230008000
us-gaap Payments To Acquire Projects
PaymentsToAcquireProjects
750000
us-gaap Operating Income Loss
OperatingIncomeLoss
133032000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3456000
us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
10633000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.96
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
7216000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
17491000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
67471000
us-gaap Other Noncash Expense
OtherNoncashExpense
750000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.39 pure
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
100101000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-30714000
us-gaap Investment Income Interest
InvestmentIncomeInterest
3235000
us-gaap Increase Decrease In Notes Receivables
IncreaseDecreaseInNotesReceivables
17000000
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
199000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
63000
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-34199000
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-199000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
52171000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
86537000 shares
us-gaap Other Payments To Acquire Businesses
OtherPaymentsToAcquireBusinesses
8000000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
18186000
us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
3114000 shares
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-112000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
136068000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.98
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
30502000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-17216000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-776000
us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
560000
us-gaap Cost Of Revenue
CostOfRevenue
37580000
us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
566000
us-gaap Other Operating Income
OtherOperatingIncome
3036000
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
32197000
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
1333000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
84715000 shares
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2180000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1822000 shares
us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
10127000
us-gaap Revenues
Revenues
363040000
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
344891000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
290854000
us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
18149000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8639000 shares
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
294005000
us-gaap Net Income Loss
NetIncomeLoss
83009000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
32197000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
151799000
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
1152000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
53059000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-138000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
825000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
6150000
mygn Segment Reporting Depreciation And Amortization
SegmentReportingDepreciationAndAmortization
6741000
mygn Amount Charged To Retained Earnings As Result Of Stock Repurchases
AmountChargedToRetainedEarningsAsResultOfStockRepurchases
44468000
mygn Amount Of Reduction In Common Stock As Result Of Stock Repurchases
AmountOfReductionInCommonStockAsResultOfStockRepurchases
23004000
CY2013Q1 us-gaap Stock Repurchase Program Authorized Amount
StockRepurchaseProgramAuthorizedAmount
200000000
CY2013Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount
174900000
CY2013Q1 us-gaap Costs And Expenses
CostsAndExpenses
98554000
CY2013Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
57918000
CY2013Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
37654000
CY2013Q1 us-gaap Share Based Compensation
ShareBasedCompensation
6731000
CY2013Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.46
CY2013Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.36 pure
CY2013Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
1434000
CY2013Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21349000
CY2013Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
259000
CY2013Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
194000
CY2013Q1 mygn Segment Reporting Depreciation And Amortization
SegmentReportingDepreciationAndAmortization
4455000
CY2013Q1 mygn Amount Charged To Retained Earnings As Result Of Stock Repurchases
AmountChargedToRetainedEarningsAsResultOfStockRepurchases
31571000
CY2013Q1 mygn Amount Of Reduction In Common Stock As Result Of Stock Repurchases
AmountOfReductionInCommonStockAsResultOfStockRepurchases
13252000
CY2013Q1 mygn Income Related To Accretion Of Note Receivable And Stated Interest Rate
IncomeRelatedToAccretionOfNoteReceivableAndStatedInterestRate
1104000
CY2012Q1 us-gaap Costs And Expenses
CostsAndExpenses
83681000
CY2013Q1 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
111000
CY2013Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-111000
CY2013Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
82434000 shares
CY2013Q1 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
1738000 shares
CY2013Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-497000
CY2013Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
59241000
CY2013Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.47
CY2013Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13618000
CY2013Q1 us-gaap Cost Of Revenue
CostOfRevenue
16462000
CY2013Q1 us-gaap Other Operating Income
OtherOperatingIncome
1323000
CY2013Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
80375000 shares
CY2013Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
2059000 shares
CY2013Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35 pure
CY2013Q1 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
3872000
CY2013Q1 us-gaap Revenues
Revenues
156472000
CY2013Q1 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
148384000
CY2013Q1 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
8088000
CY2013Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5797000 shares
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
37892000
CY2013Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
64602000
CY2012Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
46096000
CY2012Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
29769000
CY2012Q1 us-gaap Share Based Compensation
ShareBasedCompensation
6588000
CY2012Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.34
CY2012Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.38 pure
CY2012Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
1379000
CY2012Q1 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
-6000
CY2012Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
6000
CY2012Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
86462000 shares
CY2012Q1 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
502000 shares
CY2012Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
91000
CY2012Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
47481000
CY2012Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.35
CY2012Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11753000
CY2012Q1 us-gaap Cost Of Revenue
CostOfRevenue
13465000
CY2012Q1 us-gaap Other Operating Income
OtherOperatingIncome
1385000
CY2012Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
84403000 shares
CY2012Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
2059000 shares
CY2012Q1 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
3763000
CY2012Q1 us-gaap Revenues
Revenues
129777000
CY2012Q1 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
123312000
CY2012Q1 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
6465000
CY2012Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7589000 shares
CY2012Q1 us-gaap Net Income Loss
NetIncomeLoss
29615000
CY2012Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
54700000
CY2012Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17866000
CY2012Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
63000
CY2012Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
275000
CY2012Q1 mygn Segment Reporting Depreciation And Amortization
SegmentReportingDepreciationAndAmortization
2303000
CY2012Q1 mygn Amount Charged To Retained Earnings As Result Of Stock Repurchases
AmountChargedToRetainedEarningsAsResultOfStockRepurchases
8273000
CY2012Q1 mygn Amount Of Reduction In Common Stock As Result Of Stock Repurchases
AmountOfReductionInCommonStockAsResultOfStockRepurchases
3732000

Files In Submission

Name View Source Status
0001193125-13-206264-index-headers.html Edgar Link pending
0001193125-13-206264-index.html Edgar Link pending
0001193125-13-206264.txt Edgar Link pending
0001193125-13-206264-xbrl.zip Edgar Link pending
d496887d10q.htm Edgar Link pending
d496887dex311.htm Edgar Link pending
d496887dex312.htm Edgar Link pending
d496887dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
mygn-20130331.xml Edgar Link completed
mygn-20130331.xsd Edgar Link pending
mygn-20130331_cal.xml Edgar Link unprocessable
mygn-20130331_def.xml Edgar Link unprocessable
mygn-20130331_lab.xml Edgar Link unprocessable
mygn-20130331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending